Subscribe To
Bristol myers shares interim data from long-term study of zeposia in ulcerative colitis
Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term effi
February 17, 2022, 3:41 pm
Bristol myers shares interim data from long-term study of zeposia in ulcerative colitis
Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term effi
February 17, 2022, 3:41 pm
Bristol myers shares interim data from long-term study of zeposia in ulcerative colitis
Bristol Myers Squibb & Co (NYSE: BMY) has announced interim results from the True North open-label extension study evaluating the long-term effi
February 17, 2022, 3:41 pm
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy tria...
February 17, 2022, 11:40 am
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy tria...
February 17, 2022, 11:40 am
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy tria...
February 17, 2022, 11:40 am
Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients
Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...
February 17, 2022, 11:11 am
Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients
Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...
February 17, 2022, 11:11 am
Gilead's lenacapavir shows sustained efficacy in pretreated hiv patients
Gilead Sciences Inc (NASDAQ: GILD) announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir in heavily pretre...
February 17, 2022, 11:11 am
Los andes copper announces appointment of santiago montt as its chief operating officer
Los Andes Copper Ltd (TSX-V:LA) has announced the appointment of Santiago Montt as its chief operating officer (COO) and as president of Compañía Mi...
February 15, 2022, 10:03 am
Los andes copper announces appointment of santiago montt as its chief operating officer
Los Andes Copper Ltd (TSX-V:LA) has announced the appointment of Santiago Montt as its chief operating officer (COO) and as president of Compañía Mi...
February 15, 2022, 10:03 am
Los andes copper announces appointment of santiago montt as its chief operating officer
Los Andes Copper Ltd (TSX-V:LA) has announced the appointment of Santiago Montt as its chief operating officer (COO) and as president of Compañía Mi...
February 15, 2022, 10:03 am
Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens
Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...
February 11, 2022, 8:42 am
Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens
Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...
February 11, 2022, 8:42 am
Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens
Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...
February 11, 2022, 8:42 am
Novavax stock rises as covid vaccine shows 80% efficacy in adolescents
Novavax will submit applications for clearance of the shot's use in adolescents to global authorities in first quarter...
February 11, 2022, 5:32 am
Novavax stock rises as covid vaccine shows 80% efficacy in adolescents
Novavax will submit applications for clearance of the shot's use in adolescents to global authorities in first quarter...
February 11, 2022, 5:32 am
Novavax stock rises as covid vaccine shows 80% efficacy in adolescents
Novavax will submit applications for clearance of the shot's use in adolescents to global authorities in first quarter...
February 11, 2022, 5:32 am
Los andes copper reports encouraging assays from its phase i drill program at the vizcachitas copper project in chile
Los Andes Copper Ltd (TSX-V:LA) reported “excellent” drill results from its Vizcachitas copper proj...
February 10, 2022, 9:34 am
Los andes copper reports encouraging assays from its phase i drill program at the vizcachitas copper project in chile
Los Andes Copper Ltd (TSX-V:LA) reported “excellent” drill results from its Vizcachitas copper proj...
February 10, 2022, 9:34 am